Duncan Njenda

Ex-vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV type 1 non-B subtypes

Ujjwal Neogi, Kamalendra Singh, Shambhu G. Aralaguppe et al. · AIDS · 2017 · 36 citations

Medicine, Pharmacokinetics, Pharmacology +17

HIV-1 Integrase Diversity and Resistance-Associated Mutations and Polymorphisms Among Integrase Strand Transfer Inhibitor-Naive HIV-1 Patients from Cameroon

Sello Given Mikasi, Josiah Otwoma Gichana, Cheri van der Walt et al. · AIDS Research and Human Retroviruses · 2019 · 16 citations

Life Sciences, Infectious Diseases, Molecular Genetics +17

HIV-1 Subtype C with PYxE Insertion Has Enhanced Binding of Gag-p6 to Host Cell Protein ALIX and Increased Replication Fitness

Robert van Domselaar, Duncan Njenda, Rohit Rao et al. · Journal of Virology · 2019 · 15 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +13

Antiretroviral potency of 4′-ethnyl-2′-fluoro-2′-deoxyadenosine, tenofovir alafenamide and second-generation NNRTIs across diverse HIV-1 subtypes

Duncan Njenda, Shambhu G. Aralaguppe, Kamalendra Singh et al. · Journal of Antimicrobial Chemotherapy · 2018 · 14 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Pleckstrin Levels Are Increased in Patients with Chronic Periodontitis and Regulated via the MAP Kinase-p38α Signaling Pathway in Gingival Fibroblasts

Abdul Alim, Duncan Njenda, Anna Lundmark et al. · Frontiers in Immunology · 2022 · 13 citations · Full text

Dentistry, Oral Biology, Periodontics +17